16098438

Source:http://linkedlifedata.com/resource/pubmed/id/16098438

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008059, umls-concept:C0152171, umls-concept:C0252643, umls-concept:C0443252, umls-concept:C1280500
pubmed:issue	4
pubmed:dateCreated	2005-8-15
pubmed:abstractText	This study investigated the long-term outcome of children with pulmonary arterial hypertension (PAH) treated with bosentan therapy, with or without concomitant prostanoid therapy.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/M01 RR000069-457038, http://linkedlifedata.com/resource/pubmed/grant/M01 RR00069
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16098438-16098439, http://linkedlifedata.com/resource/pubmed/commentcorrection/16098438-16682327
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Endothelin A, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Endothelin B, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/bosentan
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0735-1097
pubmed:author	pubmed-author:AbmanSteven HSH, pubmed-author:BarstRobyn JRJ, pubmed-author:ClaussenLori RLR, pubmed-author:DoranAimeeA, pubmed-author:IvyD DunbarDD, pubmed-author:MorgantiAdeleA, pubmed-author:NguyenNgocN, pubmed-author:RosenzweigErika BermanEB, pubmed-author:WidlitzAllisonA, pubmed-author:YungDelphineD
pubmed:issnType	Print
pubmed:day	16
pubmed:volume	46
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	697-704
pubmed:dateRevised	2011-6-2
pubmed:meshHeading	pubmed-meshheading:16098438-Adolescent, pubmed-meshheading:16098438-Antihypertensive Agents, pubmed-meshheading:16098438-Child, pubmed-meshheading:16098438-Child, Preschool, pubmed-meshheading:16098438-Drug Therapy, Combination, pubmed-meshheading:16098438-Female, pubmed-meshheading:16098438-Humans, pubmed-meshheading:16098438-Hypertension, Pulmonary, pubmed-meshheading:16098438-Male, pubmed-meshheading:16098438-Prostaglandins, pubmed-meshheading:16098438-Receptor, Endothelin A, pubmed-meshheading:16098438-Receptor, Endothelin B, pubmed-meshheading:16098438-Retrospective Studies, pubmed-meshheading:16098438-Risk Assessment, pubmed-meshheading:16098438-Risk Factors, pubmed-meshheading:16098438-Safety, pubmed-meshheading:16098438-Sulfonamides, pubmed-meshheading:16098438-Survival Analysis, pubmed-meshheading:16098438-Time, pubmed-meshheading:16098438-Treatment Outcome
pubmed:year	2005
pubmed:articleTitle	Effects of long-term bosentan in children with pulmonary arterial hypertension.
pubmed:affiliation	Division of Pediatric Cardiology, New York Presbyterian Hospital, New York, New York 10032, USA. esb14@columbia.edu
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural